| Literature DB >> 35987700 |
Leticia Gómez-Sánchez1, Emiliano Rodríguez-Sánchez2,3,4,5, Luis García-Ortiz2,3,5,6, Manuel A Gómez-Marcos2,3,4,5, Rafel Ramos7,8,9, Ruth Marti5,7,8, Marta Gómez-Sánchez2, Cristina Lugones-Sánchez2,5, Olaya Tamayo-Morales2,5, Susana Gonzalez Sánchez2,5, Fernando Rigo5,10.
Abstract
BACKGROUND: The aim of this study was to analyze the association of physical activity and its intensity with arterial stiffness and vascular aging and differences by sex in a Spanish population with intermediate cardiovascular risk.Entities:
Keywords: Physical activity; Spanish population; Vascular aging
Mesh:
Year: 2022 PMID: 35987700 PMCID: PMC9392339 DOI: 10.1186/s13293-022-00456-w
Source DB: PubMed Journal: Biol Sex Differ ISSN: 2042-6410 Impact factor: 8.811
General characteristics of the participants globally and by sex
| Global | (2475) | Men | (1524) | Women | (951) | ||
|---|---|---|---|---|---|---|---|
| Mean or | SD or (%) | Mean or | SD or (%) | Mean or | SD or (%) | ||
| Conventional risk factors | |||||||
| Age, (years) | 61.34 | 7.70 | 61.11 | 8.11 | 61.70 | 7.00 | 0.066 |
| SBP, (mmHg) | 137.25 | 17.37 | 139.09 | 17.05 | 134.32 | 17.48 | < 0.001 |
| DBP, (mmHg) | 84.58 | 10.23 | 85.67 | 10.44 | 82.84 | 9.63 | < 0.001 |
| BP, (mmHg) | 52.66 | 14.16 | 53.40 | 14.19 | 51.47 | 14.04 | 0.001 |
| Hypertension, | 1795 | (72.5) | 1172 | (76.9) | 623 | (65.5) | < 0.001 |
| Antihypertensive drugs, | 1272 | (51.4) | 786 | (50.4) | 504 | (53.0) | 0.215 |
| Total cholesterol, (mg/dl) | 225.53 | 41.07 | 220.39 | 38.92 | 233.77 | 43.05 | < 0.001 |
| LDL cholesterol, (mg/dl) | 139.88 | 34.97 | 138.34 | 34.26 | 142.32 | 35.96 | 0.006 |
| HDL cholesterol, (mg/dl) | 49.81 | 13.03 | 47.89 | 11.96 | 52.90 | 14.04 | < 0.001 |
| Triglycerides, (mg/dl) | 146.21 | 96.48 | 150.99 | 105.90 | 138.59 | 78.63 | 0.001 |
| Dyslipidemia, | 1664 | (67.2) | 969 | (63.6) | 695 | (73.2) | < 0.001 |
| Lipid-lowering drugs, | 717 | (29.0) | 419 | (27.5) | 298 | (31.3) | 0.045 |
| FPG, (mg/dl) | 107.98 | 34.83 | 107.76 | 33.90 | 108.35 | 36.29 | 0.683 |
| HbA1c, (in %) | 6.12 | 1.18 | 6.06 | 1.12 | 6.21 | 1.26 | 0.002 |
| Diabetes mellitus, | 842 | (34.0) | 493 | (32.3) | 349 | (36.7) | 0.029 |
| Hypoglycaemic drugs, | 511 | (20.6) | 289 | (19.0) | 222 | (23.3) | 0.009 |
| Height, cm | 164.56 | 9.27 | 169.69 | 6.78 | 156.34 | 6.36 | < 0.001 |
| Weight, kg | 79.41 | 14.67 | 83.81 | 13.52 | 72.36 | 13.67 | < 0.001 |
| WC, (cm) | 100.95 | 11.68 | 102.94 | 10.52 | 97.76 | 12.69 | < 0.001 |
| BMI, (kg/m2) | 29.26 | 4.52 | 29.06 | 3.95 | 29.59 | 5.28 | 0.004 |
| Obesity, | 897 | (26.2) | 510 | (33.5) | 387 | (40.7) | < 0.001 |
| Abdominal obesity, | 1546 | (62.8) | 797 | (52.6) | 749 | (79.3) | < 0.001 |
| Plasma creatine, (mg/dl) | 0.85 | 0.23 | 0.94 | 0.24 | 0.71 | 0.13 | < 0.001 |
| GFR (ml/min/1.73 m2) | 87.47 | 14.21 | 86.79 | 14.87 | 88.56 | 13.02 | 0.003 |
| CVR, SCORE scale, (%) | 3.55 | 2.73 | 4.48 | 2.93 | 2.05 | 1.40 | < 0.001 |
| Cardiovascular diseases | |||||||
| Renal disease, | 2 | (0.1) | 2 | (0.1) | 0 | (0.0) | 0.526 |
| Peripheral arteriopathy, | 13 | (0.5) | 11 | (0.7) | 2 | (0.2) | 0.150 |
| Heart failure, | 12 | (0.5) | 11 | (0.7) | 1 | (0.1) | 0.036 |
| Lifestyles | |||||||
| Years of smoker, (years) | 31.66 | 12.82 | 31.95 | 12.78 | 30.74 | 12.92 | 0.113 |
| Smoker, | 710 | (28.7) | 486 | (31.9) | 224 | (23.7) | < 0.001 |
| Alcohol, (g/W) | 71.87 | 116.74 | 102.01 | 132.71 | 23.58 | 58.86 | < 0.001 |
| Risk consumption ( | 334 | (13.5) | 284 | (18.6) | 50 | (5.3) | < 0.001 |
| MD, (total score) | 5.18 | 1.73 | 5.09 | 1.78 | 5.32 | 1.63 | 0.002 |
| Adherence MD, | 1295 | (52.4) | 781 | (51.2) | 514 | (54.0) | 0.186 |
| Total PA, (METs/m/W) | 2462 | 2495 | 2864 | 2815 | 1817 | 1683 | < 0.001 |
| High-intensity PA, (METs/m/W) | 917 | 1661 | 1096 | 1913 | 629 | 1087 | < 0.001 |
| Moderate-intensity PA, (METs/m/W) | 811 | 1502 | 1012 | 1726 | 488 | 964 | < 0.001 |
| Low-intensity PA, (METs/m/W) | 734 | 1003 | 755 | 1047 | 700 | 927 | 0.182 |
| Sedentary, | 2127 | (85.9) | 1269 | (83.3) | 858 | (90.2) | < 0.001 |
| Vascular function | |||||||
| baPWV, (m/s) | 14.87 | 2.63 | 14.82 | 2.65 | 14.93 | 2.60 | 0.313 |
| baPWV yes sedentary, (m/s) | 14.89 | 2.64 | 14.86 | 2.67 | 15.06 | 2.61 | 0.598 |
| baPWV non sedentary MD, (m/s) | 14.74 | 2.57 | 14.65 | 2.55 | 14.92 | 2.59 | 0.191 |
Values are means ± standard deviations for continuous data and number and proportions for categorical data
Risk alcohol consumption in women were ≥ 140 g/week and in men ≥ 210 g/week. Sedentary if the moderate physical activity performed is < 675 METs min/week or the intense physical activity < 420 METs min/week. Definition American Heart Association, 2007. Adherence MD ≥ 5
N, number; SD, standard deviation; g/W, grams/week; PA, physical activity; METs/m/W, basal metabolic rate/min/week; MD, Mediterranean diet; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, pulse pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; WC, waist circumference; BMI, body mass index; CVR, cardiovascular risk; GFR, glomerular filtration; baPWV, brachial–ankle pulse wave velocity
p value: differences between men and women
Characteristics of physical activity in participants with healthy, normal and early vascular aging globally and by sex
| HVA | NVA | EVA | ||
|---|---|---|---|---|
| Global | ( | ( | ( | |
| Total PA, (METs/m/W)# | 2719 ± 2896 | 2462 ± 2479 | 2253 ± 2229 | 0.056 |
| High-intensity PA, (METs/m/W)*,# | 1214 ± 2234 | 885 ± 1600 | 886 ± 1485 | 0.014 |
| Moderate-intensity PA, (METs/m/W) | 844 ± 1606 | 827 ± 1518 | 678 ± 1296 | 0.256 |
| Low-intensity PA, (METs/m/W) | 660 ± 985 | 750 ± 551 | 688 ± 884 | 0.294 |
Values are represented as mean (standard deviation) for continuous data
Differences among groups: continuous variables analysis of variance and post hoc using the DMS tests
PA, physical activity; METs/m/W, basal metabolic rate/min/week; EVA, early vascular aging; HVA, healthy vascular aging; NVA, normal vascular aging
*p value < 0.05 between HVA and NVA
¥p value < 0.05 between NVA and EVA
#p value < 0.05 between HVA and EVA
Fig. 1Vascular aging status global and by sex in percentage. EVA early vascular aging, NVA normal vascular aging, HVA healthy vascular aging
Fig. 2Vascular aging status according to total physical activity performed in percentage. METs/m/W, metabolic equivalents/min/week
Multiple regression analysis of arterial stiffness with physical activity
| β | 95% CI | ||
|---|---|---|---|
| Total | |||
| M1 | |||
| Total PA, (METs/m/W) | − 0.045 | − 0.080 to − 0.009 | 0.013 |
| M2 | |||
| High-intensity PA, (METs/m/W) | − 0.084 | − 0.136 to − 0.032 | 0.002 |
| Moderate-intensity PA, (METs/m/W) | − 0.030 | − 0.087 to 0.028 | 0.312 |
| Low-intensity PA, (METs/m/W) | 0.042 | − 0.043 to 0.127 | 0.334 |
| Men | |||
| M1 | |||
| Total PA, (METs/m/W) | − 0.049 | − 0.089 to − 0.009 | 0.017 |
| M2 | |||
| High-intensity PA, (METs/m/W) | − 0.097 | − 0.156 to − 0.039 | 0.001 |
| Moderate-intensity PA, (METs/m/W) | − 0.024 | − 0.089 to 0.040 | 0.463 |
| Low-intensity PA, (METs/m/W) | 0.059 | − 0.049 to 0.166 | 0.283 |
| Women | |||
| M1 | |||
| Total PA, (METs/m/W) | − 0.021 | − 0.099 to 0.057 | 0.595 |
| M2 | |||
| High-intensity PA, (METs/m/W) | − 0.014 | − 0.134 to 0.106 | 0.817 |
| Moderate-intensity PA, (METs/m/W) | − 0.045 | − 0.182 to 0.092 | 0.519 |
| Low-intensity PA, (METs/m/W) | − 0.003 | − 0.145 to 0.138 | 0.961 |
Model 1. Multiple regression analysis using baPWV m/s as dependent variables, total physical activity independent variable, and age (years), sex (woman = 1 and man = 2), years of smoker, alcohol consumption in g/week, Mediterranean diet adherence score, systolic blood pressure in mmHg; glycosylated hemoglobin in %, body mass index, antihypertensive drugs, lipid-lowering drugs and hypoglycaemic drugs (Yes = 1 and Non = 0) as adjustment variables
Model 2. Multiple regression analysis using baPWV m/s as dependent variables, high-intensity physical activity, moderate-intensity physical activity and low-intensity physical activity independent variable, and age (years), sex (woman = 1 and man = 2), years of smoker in years, alcohol consumption in g/week, Mediterranean diet adherence score, systolic blood pressure in mmHg; glycosylated hemoglobin in %, body mass index, antihypertensive drugs, lipid-lowering drugs and hypoglycaemic drugs (Yes = 1 and Non = 0) as adjustment variables
M1, model 1; M2, model 2; PA, physical activity; METs/m/W, metabolic equivalents/min/week
Association of physical activity with vascular aging
| Physical activity | OR | 95% CI | ||
|---|---|---|---|---|
| HVA (reference) | ||||
| Total | ||||
| M1 | Total PA, (METs/m/W) | 0.946 | 0.898 to 0.997 | 0.037 |
| M2 | High-intensity PA, (METs/m/W) | 0.903 | 0.840 to 0.971 | 0.006 |
| NVA | Moderate-intensity PA, (METs/m/W) | 0.971 | 0.887 to 1.063 | 0.526 |
| Low-intensity PA, (METs/m/W) | 1.079 | 0.928 to 1.255 | 0.325 | |
| M1 | Total PA, (METs/m/W) | 0.916 | 0.852 to 0.986 | 0.019 |
| M2 | High-intensity PA, (METs/m/W) | 0.905 | 0.818 to 1.000 | 0.050 |
| EVA | Moderate-intensity PA, (METs/m/W) | 0.900 | 0.792 to 1.024 | 0.109 |
| Low-intensity PA, (METs/m/W) | 1.035 | 0.852 to 1.256 | 0.731 | |
| Men | ||||
| M1 | Total PA, (METs/m/W) | 0.932 | 0.882 to 0.986 | 0.013 |
| M2 | High-intensity PA, (METs/m/W) | 0.898 | 0.832 to 0.969 | 0.006 |
| NVA | Moderate-intensity PA, (METs/m/W) | 0.958 | 0.870 to 1.054 | 0.377 |
| Low-intensity PA, (METs/m/W) | 1.033 | 0.866 to 1.230 | 0.716 | |
| M1 | Total PA, (METs/m/W) | 0.908 | 0.840 to 0.982 | 0.016 |
| M2 | High-intensity PA, (METs/m/W) | 0.896 | 0.804 to 0.998 | 0.046 |
| EVA | Moderate-intensity PA, (METs/m/W) | 0.897 | 0.781 to 1.029 | 0.835 |
| Low-intensity PA, (METs/m/W) | 1.020 | 0.814 to 1.277 | 0.121 | |
| Women | ||||
| M1 | Total PA, (METs/m/W) | 1.045 | 0.902 to 1.211 | 0.558 |
| M2 | High-intensity PA, (METs/m/W) | 0.965 | 0.781 to 1.191 | 0.739 |
| NVA | Moderate-intensity PA, (METs/m/W) | 1.078 | 0.827 to 1.406 | 0.578 |
| Low-intensity PA, (METs/m/W) | 1.194 | 0.892 to 1.597 | 0.233 | |
| M1 | Total PA, (METs/m/W) | 1.023 | 0.845 to 1.238 | 0.816 |
| M2 | High-intensity PA, (METs/m/W) | 0.996 | 0.750 to 1.322 | 0.976 |
| EVA | Moderate-intensity PA, (METs/m/W) | 1.031 | 0.733 to 1.450 | 0.862 |
| Low-intensity PA, (METs/m/W) | 1.102 | 0.757 to 1.603 | 0.614 | |
Multinomial logistic regression analysis
Model 1. Multiple logistic regression analysis using vascular aging (HVA = 1; NVA = 2 and EVA = 3) as dependent variables (HVA reference), total physical as independent variable, as adjustment variables in the global analysis: age in years, consumption of alcohol in grams/week, years of smoking, sex (woman = 1 and man = 2), adherence to the Mediterranean diet, type 2 diabetes mellitus, arterial hypertension, obesity, antihypertensive drugs, lipid-lowering drugs and hypoglycaemic drugs (Yes = 1 and Non = 0) as adjustment variables). Model Fitting Criteria-2 Log Likelihood of Reduced Model
Model 2. Multiple logistic regression analysis using vascular aging (HVA = 1; NVA = 2 and EVA = 3) as dependent variables (HVA reference), high-intensity physical activity, moderate-intensity physical activity and low-intensity physical activity independent variable, as adjustment variables age in years, consumption of alcohol in grams/week,, years of smoking, sex (woman = 1 and man = 2), adherence to the Mediterranean diet, type 2 diabetes mellitus, arterial hypertension, obesity, antihypertensive drugs, lipid-lowering drugs and hypoglycaemic drugs (Yes = 1 and Non = 0) as adjustment variables. Model Fitting Criteria -2 Log Likelihood of Reduced Model
M1, Model 1: M2, Model 2; HVA, healthy vascular aging; NVA, normal vascular aging; EVA, early vascular aging; PA, physical activity; METs/m/W, metabolic equivalents/min/week